Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results
Advancing transformation into a diversified biomedical innovation company with a clear path to cash flow positive Oramed strategic transaction receives shareholder approval; Lifeward gains new oral protein delivery technology platform Lifeward already …